Gevokizumab | Interleukin Related interleukin-related.com

Product Name :
Gevokizumab

Search keywords :
Gevokizumab

drugId :
null

Target Vo:
Interleukin-1 beta

Target Vo Short Name :
IL1B

Moa_Name:
Interleukin-1 beta inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Xoma Corp

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Colorectal Neoplasms

In Active Indication_Name:
Cryopyrin-Associated Periodic Syndromes

Termination Status :

China Termination Status :
Phase 3 Clinical

Highest Status:
Phase 1 Clinical

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fibronectin Antibody
MEK1 Antibody
Histone H2B Antibody (YA737): Histone H2B Antibody (YA737) is a non-conjugated and Mouse origined monoclonal antibody about 14 kDa, targeting to Histone H2B (7E2). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts